What are the signs of twin to twin transfusion syndrome (TTTS) in a monochorionic diamniotic twin pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs of Twin-to-Twin Transfusion Syndrome

TTTS is diagnosed by ultrasound when two specific criteria are met: (1) confirmed monochorionic diamniotic twin pregnancy, and (2) oligohydramnios (maximal vertical pocket ≤2 cm) in the donor twin's sac combined with polyhydramnios (maximal vertical pocket ≥8 cm) in the recipient twin's sac. 1

Essential Diagnostic Criteria

The diagnosis requires both of the following findings on prenatal ultrasound 1:

  • Monochorionic diamniotic (MCDA) placentation - This must be confirmed, as TTTS only occurs in pregnancies sharing a single placenta 1
  • Discordant amniotic fluid volumes - Specifically oligohydramnios (MVP ≤2 cm) in one sac AND polyhydramnios (MVP ≥8 cm) in the other sac, representing the 5th and 95th percentiles respectively 1

Key Ultrasound Findings by Twin

Donor Twin Signs

  • Oligohydramnios with maximal vertical pocket ≤2 cm 1
  • Small or absent bladder - nonvisualization of the fetal bladder is a pathognomonic finding 1
  • "Stuck twin" appearance - the donor appears trapped against the uterine wall, contained within the collapsed intertwin membrane due to severe oligohydramnios 1
  • Intrauterine growth restriction may be present but is not required for diagnosis 1

Recipient Twin Signs

  • Polyhydramnios with maximal vertical pocket ≥8 cm 1
  • Large, distended bladder visible on ultrasound 1, 2
  • Cardiomegaly (enlarged heart) in more advanced stages 1, 3
  • Hydrops fetalis (fluid accumulation) in severe cases 1, 3

Advanced Stage Findings

In more severe TTTS (stages II-IV), additional Doppler and cardiac findings emerge 1:

  • Abnormal umbilical artery Doppler - absent or reversed end-diastolic flow in the donor twin 1
  • Cardiac dysfunction - tricuspid regurgitation or reversal of A-wave in ductus venosus 1
  • Cardiac chamber enlargement in the recipient twin 1
  • Atrioventricular valve regurgitation in the recipient 3

Important Clinical Caveats

Growth discordance alone does NOT diagnose TTTS - while growth differences ≥20% often accompany TTTS, discordance or intrauterine growth restriction by themselves are not diagnostic criteria 1. The amniotic fluid discordance is the defining feature.

Subjective fluid differences require close monitoring - if amniotic fluid appears different between sacs but doesn't meet the strict MVP criteria (≤2 cm and ≥8 cm), progression to TTTS occurs in 15% of cases 1. These pregnancies need serial ultrasound surveillance every 2 weeks starting around 16 weeks gestation 1.

Timing of presentation matters - the most severe cases typically become evident before 20 weeks gestation, while milder forms may not appear until 26-28 weeks 1. TTTS generally arises between 15-26 weeks gestation 2.

Differential diagnosis - selective IUGR or a fetal anomaly causing amniotic fluid abnormality in one twin can mimic TTTS and must be excluded 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Twin-to-twin transfusion syndrome: prenatal diagnosis and treatment.

American journal of perinatology, 2014

Research

Fetal and Neonatal Circulatory Disorders in Twin to Twin Transfusion Syndrome (The Secondary Publication).

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2019

Related Questions

What are the risks, management, and treatment options for a patient with twin-to-twin transfusion syndrome (TTS) in a monochorionic diamniotic (MCDA) twin pregnancy, characterized by polyhydramnios and oligohydramnios?
What is the most appropriate next step in managing a 36-year-old primigravid woman with a monochorionic-diamniotic (mono-di) twin pregnancy at 27 weeks gestation, with normal fetal heart rates and no other complications?
What is the main difference between chronic polyhydramnios and acute polyhydramnios?
What differentiates chronic polyhydramnios from acute polyhydramnios?
What is the most appropriate next step in management for a 24-week pregnant woman with monochorionic (having a single placenta and chorion) twin pregnancy and twin-to-twin transfusion syndrome (TTTS)?
What is the likely cause of dizziness in a 22-year-old pregnant woman at 22 weeks gestation, with stable blood pressure, normal pregnancy scans, and episodes of dizziness lasting about 10 minutes after meals, who has not been taking her prescribed iron tablets due to constipation?
Why can an adult patient with no significant medical history and normal urine analysis have bacteriuria without symptoms of a urinary tract infection?
Can a patient with Graves' disease, who is stable on methimazole (antithyroid medication) treatment, receive methimazole dosing every couple of days for maintenance treatment?
How often can a patient with thrombocytosis, specifically essential thrombocythemia, undergo therapeutic phlebotomy?
Can Gate P (prostaglandin analogue) eye drops induce vomiting in patients with glaucoma or ocular hypertension, particularly in older adults?
Can a combination of gatifloxacin (antibiotic) and prednisolone (corticosteroid) eye drops induce vomiting, particularly in patients with a history of gastrointestinal issues?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.